New insights into macrophage heterogeneity in renal injury and repair

Yahong Xu1, Jingping Liu1

  • 1Department of General Surgery and NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

The FEBS Journal
|December 15, 2025
PubMed

Insights

Macrophages play key roles in acute kidney injury (AKI). Monocyte-derived macrophages (Mo-MФs) worsen AKI, while resident macrophages promote kidney repair through efferocytosis.

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Macrophages (MФs) are critical in acute kidney injury (AKI) but their specific roles in renal injury and repair are not fully understood.
  • Understanding macrophage heterogeneity is crucial for developing targeted therapies for AKI.

Purpose of the Study:

  • To investigate the dynamic changes and functional heterogeneity of macrophages during cisplatin-induced AKI.
  • To elucidate the distinct roles of different macrophage subsets in AKI progression and regression.

Main Methods:

  • Single-cell RNA sequencing was employed to analyze macrophage populations at various stages of AKI.
  • Analysis focused on identifying distinct macrophage subsets and their gene expression profiles.

Main Results:

  • Four distinct renal macrophage subsets were identified.
  • Monocyte-derived MФs (Mo-MФs) were found to drive renal inflammation during AKI progression.
  • Renal resident Cx3cr1+ MФs were identified as crucial for renal repair, mediating efferocytosis via AXL-GAS6 signaling during AKI regression.

Conclusions:

  • This study reveals the heterogeneity of macrophage responses in AKI, differentiating between pro-inflammatory and pro-repair subsets.
  • The findings highlight the distinct roles of Mo-MФs and resident MФs in AKI pathogenesis and resolution.
  • Targeting specific macrophage subsets, particularly resident MФs and their efferocytic pathways, may offer therapeutic strategies for AKI.